Home8AW0 • FRA
add
Ocean Biomedical Inc
Market cap
1.29M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 958.00K | 61.01% |
Net income | -8.24M | -163.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | 1.58M | -46.30% |
Total liabilities | 93.98M | 19.37% |
Total equity | -92.40M | — |
Shares outstanding | 91.02M | — |
Price to book | — | — |
Return on assets | -192.83% | — |
Return on capital | 3.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.24M | -163.39% |
Cash from operations | -356.00K | 26.60% |
Cash from investing | — | — |
Cash from financing | 909.00K | — |
Net change in cash | 553.00K | 214.02% |
Free cash flow | -1.82M | -159.87% |
About
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Founded
2019
Headquarters
Website
Employees
7
